Business
Why the Orthocell (ASX:OCC) share price is edging higher today
The Orthocell Ltd (ASX: OCC) share price is edging higher today. This comes after the company announced it has completed an important step to obtaining its commercial licence in Australia for its CelGro medical device.
During market open, the Orthocell share price reached as high as 43.5 cents. However, at the time of writing, the company’s shares have slightly retreated to 42.5 cents, up 1.2%.
Quick take on Orthocell
Orthocell focuses on the development and commercialisation of novel collagen medical devices and cellular therapies.
Its lead product, CelGro, facilitates tissue repair and healing in a variety of orthopaedic, reconstructive and surgical applications. This includes treating defects in areas of the body such as…
-
Noosa News8 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News15 hours agoFarmer Fred Perry’s 30-year conservation project creates bird haven after years of ‘bashing and burning’
-
General14 hours agoBoy dies after being trapped between rocks off NSW beach
-
Noosa News15 hours agoDetectives continue to search for answers on Crystal Beale’s death